What is it about?

There are suprisingly few physiologically relevant model systems for drug discovery programs and/or investigations of mechanisms of human disease. This work investigates how podocytes derived from different sources (two derived from Alport Syndrome patients, one from a renal disease free individual and one immortalized cell line) respond to two activators of G-protein coupled receptors, calcium and angiotensin II. While all four cell lines are fundamentally different, the most consistent feature is what appears to be the opening of calcium-dependent potassium channels in the immortalized and renal-disease free podocyte-like cells, but not in the Alport Syndrome patient derived cells.

Featured Image

Why is it important?

This work shows the feasibility of using human pluripotent stem cells to create model systems relevant to human disease. With a little tweaking this system could easily be employed for high throughput drug screening for podocyte (or other renal cell) protective compounds.

Read the Original

This page is a summary of: Induced Pluripotent Stem Cell–Derived Podocyte-Like Cells as Models for Assessing Mechanisms Underlying Heritable Disease Phenotype: Initial Studies Using Two Alport Syndrome Patient Lines Indicate Impaired Potassium Channel Activity, Journal of Pharmacology and Experimental Therapeutics, August 2018, American Society for Pharmacology & Experimental Therapeutics (ASPET),
DOI: 10.1124/jpet.118.250142.
You can read the full text:

Read

Contributors

The following have contributed to this page